Stephen Russell

Company: Vyriad, Inc.
Job title: Chief Executive Officer
Seminars:
Intravenous Administration of an Oncolytic Vesicular Stomatitis Virus: Clinical Experience to Date 9:00 am
Voyager V1 has been administered intravenously to over 100 cancer patients in clinical trials Compelling evidence of single agent activity after a single infusion will be presentedRead more
day: Day Two